Loading...

Jose V Torres

Title(s)Professor, Medical Microbiology and Immunology
SchoolUniversity of California, Davis
Phone530-752-3157
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Pérez Rodríguez NM, Galloway R, Blau DM, Traxler R, Bhatnagar J, Zaki SR, Rivera A, Torres JV, Noyd D, Santiago-Albizu XE, Rivera García B, Tomashek KM, Bower WA, Sharp TM. Case series of fatal Leptospira spp./dengue virus co-infections-Puerto Rico, 2010-2012. Am J Trop Med Hyg. 2014 Oct; 91(4):760-5. PMID: 25092820.
      View in: PubMed
    2. Marquez JP, Rivera R, Kang KH, Gardner MB, Torres JV. Human papillomavirus immunogen that provides protective tumor immunity and induces tumor regression. Viral Immunol. 2012 Apr; 25(2):141-52. PMID: 22486305.
      View in: PubMed
    3. Ghunaim H, Kumar A, Torres J, Diaz-Mitoma F, Azizi A. An immunological comparison between lipidated and non-lipidated multivalent HIV-1 peptides representing Gp120 and Gag hypervariable regions. Vaccine. 2011 Aug 11; 29(35):5950-8. PMID: 21718739.
      View in: PubMed
    4. Brentlinger PE, Torres JV, Martínez PM, Ghee A, Lujan J, Bastos R, Manuel R, Mudender FM, Assan A. Clinical staging of HIV-related illness in Mozambique: performance of nonphysician clinicians based on direct observation of clinical care and implications for health worker training. J Acquir Immune Defic Syndr. 2010 Nov; 55(3):351-5. PMID: 20562630.
      View in: PubMed
    5. Brentlinger PE, Assan A, Mudender F, Ghee AE, Vallejo Torres J, Martínez Martínez P, Bacon O, Bastos R, Manuel R, Ramirez Li L, McKinney C, Nelson LJ. Task shifting in Mozambique: cross-sectional evaluation of non-physician clinicians' performance in HIV/AIDS care. Hum Resour Health. 2010 Oct 12; 8:23. PMID: 20939909.
      View in: PubMed
    6. Kang KH, Yamamura Y, Carlos MP, Karvelas N, Kim IS, Sunkara D, Rivera R, Gardner MB, Anderson DE, Diaz-Mitoma F, Torres J, Marquez JP. Synthetic antigens representing the antigenic variation of human hepatitis C virus. Viral Immunol. 2010 Oct; 23(5):497-508. PMID: 20883164.
      View in: PubMed
    7. Azizi A, Anderson DE, Torres JV, Ogrel A, Ghorbani M, Soare C, Sandstrom P, Fournier J, Diaz-Mitoma F. Induction of broad cross-subtype-specific HIV-1 immune responses by a novel multivalent HIV-1 peptide vaccine in cynomolgus macaques. J Immunol. 2008 Feb 15; 180(4):2174-86. PMID: 18250424.
      View in: PubMed
    8. Rigau-Pérez JG, Torres JV, Mosely Hayes J, Vorndam V, Clark GG. Medical examiner samples: a source for dengue surveillance. P R Health Sci J. 2006 Mar; 25(1):67-9. PMID: 16883680.
      View in: PubMed
    9. Anderson DE, Singapuri A, Kang KH, Montefiori DC, Torres JV. Timing of retroviral infection influences anamnestic immune response in vaccinated primates. Viral Immunol. 2005; 18(4):689-94. PMID: 16359235.
      View in: PubMed
    10. Reddy KJ, Banapour B, Anderson DE, Lee SH, Marquez JP, Carlos MP, Torres JV. Induction of immune responses against human papillomaviruses by hypervariable epitope constructs. Immunology. 2004 Jun; 112(2):321-7. PMID: 15147575.
      View in: PubMed
    11. Carlos MP, Yamamura Y, Vu Q, Conzen K, Anderson DE, Torres JV. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b. Clin Immunol. 2004 Apr; 111(1):22-7. PMID: 15093548.
      View in: PubMed
    12. Anderson DE, Llenado RA, Torres JV. Humoral immunity and the evolution of HIV-2. Viral Immunol. 2004; 17(3):436-9. PMID: 15357909.
      View in: PubMed
    13. Rendón-Maldonado J, Espinosa-Cantellano M, Soler C, Torres JV, Martínez-Palomo A. Trichomonas vaginalis: in vitro attachment and internalization of HIV-1 and HIV-1-infected lymphocytes. J Eukaryot Microbiol. 2003 Jan-Feb; 50(1):43-8. PMID: 12674478.
      View in: PubMed
    14. Suzuki S, Carlos MP, Chuang LF, Torres JV, Doi RH, Chuang RY. Methadone induces CCR5 and promotes AIDS virus infection. FEBS Lett. 2002 May 22; 519(1-3):173-7. PMID: 12023039.
      View in: PubMed
    15. Hel Z, Nacsa J, Kelsall B, Tsai WP, Letvin N, Parks RW, Tryniszewska E, Picker L, Lewis MG, Edghill-Smith Y, Moniuszko M, Pal R, Stevceva L, Altman JD, Allen TM, Watkins D, Torres JV, Berzofsky JA, Belyakov IM, Strober W, Franchini G. Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques. J Virol. 2001 Dec; 75(23):11483-95. PMID: 11689630.
      View in: PubMed
    16. Anderson DE, Carlos MP, Nguyen L, Torres JV. Overcoming original (antigenic) sin. Clin Immunol. 2001 Nov; 101(2):152-7. PMID: 11683574.
      View in: PubMed
    17. Gov Y, Bitler A, Dell'Acqua G, Torres JV, Balaban N. RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis. Peptides. 2001 Oct; 22(10):1609-20. PMID: 11587789.
      View in: PubMed
    18. Smith JM, Torres JV. A retroviral DNA vaccine vector. Viral Immunol. 2001; 14(4):339-48. PMID: 11792063.
      View in: PubMed
    19. Miyagi T, Chuang LF, Doi RH, Carlos MP, Torres JV, Chuang RY. Morphine induces gene expression of CCR5 in human CEMx174 lymphocytes. J Biol Chem. 2000 Oct 06; 275(40):31305-10. PMID: 10887175.
      View in: PubMed
    20. Balaban N, Collins LV, Cullor JS, Hume EB, Medina-Acosta E, Vieira da Motta O, O'Callaghan R, Rossitto PV, Shirtliff ME, Serafim da Silveira L, Tarkowski A, Torres JV. Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides. 2000 Sep; 21(9):1301-11. PMID: 11072116.
      View in: PubMed
    21. Muñoz JF, Salmen S, Berrueta LR, Carlos MP, Torres JV. Reply. J Infect Dis. 2000 Mar; 181(3):1215-1216. PMID: 10720560.
      View in: PubMed
    22. Leung NJ, Aldovini A, Young R, Jarvis MA, Smith JM, Meyer D, Anderson DE, Carlos MP, Gardner MB, Torres JV. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins. Virology. 2000 Mar 01; 268(1):94-103. PMID: 10683331.
      View in: PubMed
    23. Carlos MP, Anderson DE, Gardner MB, Torres JV. Immunogenicity of a vaccine preparation representing the variable regions of the HIV type 1 envelope glycoprotein. AIDS Res Hum Retroviruses. 2000 Jan 20; 16(2):153-61. PMID: 10659054.
      View in: PubMed
    24. Smith JM, Leung NJ, Torres JV. Preparation and induction of immune responses by a DNA AIDS vaccine. Viral Immunol. 2000; 13(3):343-51. PMID: 11016598.
      View in: PubMed
    25. Carlos MP, Yamamura Y, Díaz-Mitoma F, Torres JV. Antibodies from HIV-positive and AIDS patients bind to an HIV envelope multivalent vaccine. J Acquir Immune Defic Syndr. 1999 Dec 01; 22(4):317-24. PMID: 10634192.
      View in: PubMed
    26. Muñoz JF, Salmen S, Berrueta LR, Carlos MP, Cova JA, Donis JH, Hernández MR, Torres JV. Effect of human immunodeficiency virus type 1 on intracellular activation and superoxide production by neutrophils. J Infect Dis. 1999 Jul; 180(1):206-10. PMID: 10353882.
      View in: PubMed
    27. Meyer D, Torres JV. Hypervariable epitope construct: a synthetic immunogen that overcomes MHC restriction of antigen presentation. Mol Immunol. 1999 Jul; 36(10):631-7. PMID: 10509814.
      View in: PubMed
    28. Anderson DE, Torres JV. Simian retrovirus receptor and neutralization mechanism by antibodies to the envelope glycoprotein. Viral Immunol. 1999; 12(1):47-56. PMID: 10333242.
      View in: PubMed
    29. Vu HM, Myers D, de Lorimier R, Matthews TJ, Moody MA, Heinly C, Torres JV, Haynes BF, Spicer L. Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodies. J Virol. 1999 Jan; 73(1):746-50. PMID: 9847381.
      View in: PubMed
    30. Meyer D, Torres JV. Induction of cytotoxic and helper T cell responses by modified simian immunodeficiency virus hypervariable epitope constructs. Viral Immunol. 1999; 12(2):117-29. PMID: 10413358.
      View in: PubMed
    31. Meyer D, Anderson DE, Gardner MB, Torres JV. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques. AIDS Res Hum Retroviruses. 1998 Jun 10; 14(9):751-60. PMID: 9643375.
      View in: PubMed
    32. Weinberg J, Liao HX, Torres JV, Matthews TJ, Robinson J, Haynes BF. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4. AIDS Res Hum Retroviruses. 1997 May 20; 13(8):657-64. PMID: 9168234.
      View in: PubMed
    33. Kraiselburd EN, Torres JV. Properties of virus-like particles produced by SIV-chronically infected human cell clones. Cell Mol Biol (Noisy-le-grand). 1995; 41 Suppl 1:S41-52. PMID: 8574147.
      View in: PubMed
    34. Mitchell WM, Torres J, Johnson PR, Hirsch V, Yilma T, Gardner MB, Robinson WE. Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques. AIDS. 1995 Jan; 9(1):27-34. PMID: 7893438.
      View in: PubMed
    35. Kwang J, Torres JV. Oligopeptide-based enzyme immunoassay for ovine lentivirus antibody detection. J Clin Microbiol. 1994 Jul; 32(7):1813-5. PMID: 7929780.
      View in: PubMed
    36. Anderson DE, Malley A, Benjamini E, Gardner MB, Torres JV. Hypervariable epitope constructs as a means of accounting for epitope variability. Vaccine. 1994 Jun; 12(8):736-40. PMID: 7522382.
      View in: PubMed
    37. Haynes BF, Torres JV, Langlois AJ, Bolognesi DP, Gardner MB, Palker TJ, Scearce RM, Jones DM, Moody MA, McDanal C. Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides. J Immunol. 1993 Aug 01; 151(3):1646-53. PMID: 8335949.
      View in: PubMed
    38. Torres JV, Malley A, Banapour B, Anderson DE, Axthelm MK, Gardner MB, Benjamini E. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation. AIDS Res Hum Retroviruses. 1993 May; 9(5):423-30. PMID: 7686386.
      View in: PubMed
    39. Torres JV, Anderson DE, Malley A, Banapour B, Axthelm MK, Benjamini E, Gardner MB. SIV envelope glycoprotein epitopes recognized by antibodies from infected or vaccinated rhesus macaques. J Med Primatol. 1993 Feb-May; 22(2-3):129-37. PMID: 7692056.
      View in: PubMed
    40. Malley A, Pangares N, Mayo SK, Zeleny-Pooley M, Torres JV, Benjamin E, Axthelm MK. Type D SRV-2 virus-specific CD8+ and CD4- CD8- T cells that regulate virus-induced T cell proliferation in Celebes macaques. J Med Primatol. 1993 Feb-May; 22(2-3):80-5. PMID: 7692057.
      View in: PubMed
    41. Haynes BF, Yasutomi Y, Torres JV, Gardner MB, Langlios AJ, Bolognesi DP, Matthews TJ, Scearce RM, Jones DM, Moody MA. Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy. Trans Assoc Am Physicians. 1993; 106:33-41. PMID: 8036743.
      View in: PubMed
    42. Malley A, Torres JV, Benjamini E, Pangares N, Axthelm M. Characterization of T cell epitopes on the envelope glycoprotein of simian retrovirus 1 and 2 (SRV-1 and SRV-2) in several mouse strains. Mol Immunol. 1992 Jul-Aug; 29(7-8):999-1004. PMID: 1378937.
      View in: PubMed
    43. van Kuyk RW, Acevedo RA, Torres JV, Levy NB, Planelles V, Munn RJ, Unger RE, Gardner MB, Luciw PA. Characterization of rhesus macaque B-lymphoblastoid cell lines infected with simian type D retrovirus. AIDS Res Hum Retroviruses. 1991 Nov; 7(11):899-909. PMID: 1662056.
      View in: PubMed
    44. Torres JV, Werner LL, Malley A, Benjamini E. The induction of neutralizing antibodies by synthetic peptides of the envelope protein of type D simian retrovirus-1 (SRV-1). Mol Immunol. 1991 Aug; 28(8):907-13. PMID: 1652065.
      View in: PubMed
    45. Werner LL, Torres JV, Leung CY, Kwang HS, Malley A, Benjamini E. Immunobiological properties of a recombinant simian retrovirus-1 envelope protein and a neutralizing monoclonal antibody directed against it. Mol Immunol. 1991 Aug; 28(8):819-26. PMID: 1715026.
      View in: PubMed
    46. Torres JV, Werner LL, Malley A, Benjamin E. Neutralization epitope in the envelope glycoprotein of simian retrovirus-1 (SRV-1) and identification of the virus receptor. J Med Primatol. 1991 Jun; 20(4):218-21. PMID: 1719206.
      View in: PubMed
    47. Malley A, Werner L, Benjamini E, Leung CY, Torres J, Pangares N, Shiigi S, Axthelm M. Characterization of T- and B-cell epitopes of a simian retrovirus (SRV-2) envelope protein. J Med Primatol. 1991 Jun; 20(4):177-81. PMID: 1719205.
      View in: PubMed
    48. Benjamini E, Torres JV, Werner LL, Malley A. Isolation and characterization of the neutralizable epitope of simian retrovirus-1 (SRV-1) and of the cell receptor for the virus. Adv Exp Med Biol. 1991; 303:71-7. PMID: 1725239.
      View in: PubMed
    49. Werner LL, Malley A, Torres JV, Leung CY, Kwang HS, Benjamini E. Synthetic peptides of envelope proteins of two different strains of simian AIDS retrovirus (SRV-1 and SRV-2) represent unique antigenic determinants for serum neutralizing antibodies. Mol Immunol. 1990 Nov; 27(11):1103-11. PMID: 1701027.
      View in: PubMed
    50. Atassi MZ, Torres JV, Wyde PR. Cytotoxic and helper T-lymphocyte responses to antibody recognition regions on influenza virus hemagglutinin. Adv Exp Med Biol. 1989; 251:49-63. PMID: 2532857.
      View in: PubMed
    51. Torres JV, Wyde PR, Atassi MZ. Cytotoxic T lymphocyte recognition sites on influenza virus hemagglutinin. Immunol Lett. 1988 Sep; 19(1):49-53. PMID: 3263948.
      View in: PubMed
    52. Torres JV, Yoshioka N, Atassi MZ. Antigenic regions on the beta chain of human chorionic gonadotropin and development of hormone specific antibodies. Immunol Invest. 1987 Nov; 16(7):607-18. PMID: 2450842.
      View in: PubMed